Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q2 2018 Earnings

9AugExpected

Q3 2017

Q4 2017

Q1 2018

Q2 2018

-12.25

-8.29

-4.32

-0.36

Details

Expected EPS

-0.36

Actual EPS

-11.5

Surprise EPS

-11.14

Surprise Percent

+3,094.44%

Description

Spyre Therapeutics (SYRE) has reported earnings of -11.5 per share for Q2 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.